Our Clinical Sites and Trials

Trials Sites

Results

Enter location to sort by distance.

Trial

Research Area

Duration

Locations

A5128: Plan for Obtaining Informed Consent to use Stored Human Biological Materials (HBM) for Currently Unspecified Analysis.

Designed to develop a standard operating procedure to establish a storage bank for specimens for future HIV DNA analyses. Informed…

Open and enrolling

Hepatitis, HIV comorbidities and complications, HIV Cure, HIV Treatment, Tuberculosis

See locations
A5321: Decay of HIV-1 Reservoirs in Participants on Long-Term Antiretroviral Therapy: The ACTG HIV Reservoirs Cohort (AHRC) Study

AHRC (pronounced “ARC”) is a study of differences and changes over time in HIV reservoirs (groups of HIV-infected cells that…

Open and enrolling

HIV Cure, Treatment Experienced

Participants will be expected to stay in the study for about 7 years.

See locations
A5386: A Phase 1 Clinical Trial of the Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) with and without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption

Scientists are looking for ways to effectively clear HIV that rests in areas of the body where standard antiretroviral treatment…

Open and enrolling

HIV Cure

Maximum of 2 years. Arm A will receive one dose of N-803 at Week 1 and then every 3 weeks for a total of eight doses.

See locations